Versatope Therapeutics
Dr. Tripp is a Professor in the Department of Infectious Diseases in the College of Veterinary Medicine at the University of Georgia and is a Georgia Research Alliance Eminent Scholar. His research focuses on the development of translational disease intervention approaches for emerging respiratory viruses and the mechanisms of immunity and disease pathogenesis associated with respiratory virus infection. He also studies the conceptual and functional differences between innate and adaptive immune responses that provide the foundation necessary to develop therapeutic protocols and vaccines that will confer long-term protective immunity.
This person is not in the org chart
This person is not in any offices
Versatope Therapeutics
Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.